Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Combined Treatment of Apatinib With Docetaxel as Post Second-line Therapy in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)

NCT03416231 is registered in ClinicalTrials.gov with Affiliated Hospital of North Sichuan Medical College as lead sponsor.

NCT NCT03416231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03416231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Combined Treatment of Apatinib With Docetaxel as Post Second-line Therapy in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)
Lead sponsor
Affiliated Hospital of North Sichuan Medical College
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2016
Completion date
January 1, 2020
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc